Improved ELISPOT protocol for monitoring Th1/Th17 T-cell response following T.gondii infection In...
News & Publications
Nanoparticles Can Enhance the Infection of Epithelial Cells with an Enterovirus
Vaxinano is pleased to present the latest publication that our team contributed to: “Nanoparticles...
Vaxinano Announces Exclusive Licensing Agreement with Vetoquinol
October 2024 – Today, Vaxinano announced an exclusive license agreement with Vetoquinol to develop...
Human T-cell activation with Toxoplasma gondii antigens
Human T-cell activation with Toxoplasma gondii antigens loaded in maltodextrin nanoparticles...
Vaxinano Secures €6 Million in Funding to Advance Nasal Vaccines to Clinical Trials
Vaxinano, sept 25th 2024, Lille- France : Vaxinano Secures €6 Million in Funding to Advance Nasal...
Video Vaxinano STELLAR-NP
Title: Pioneering Vaccine Solutions with Vaxinano’s STELLAR-NP Platform Description:Vaxinano is...